Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.

Ueda SM, Kapp DS, Cheung MK, Shin JY, Osann K, Husain A, Teng NN, Berek JS, Chan JK.

Am J Obstet Gynecol. 2008 Feb;198(2):218.e1-6. doi: 10.1016/j.ajog.2007.08.075.

PMID:
18226630
[PubMed - indexed for MEDLINE]
2.

Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer.

Chan JK, Kapp DS, Cheung MK, Shin JY, Stieglitz D, Husain A, Teng NN, Berek JS, Osann K, Guo H.

Am J Obstet Gynecol. 2008 Feb;198(2):216.e1-5. doi: 10.1016/j.ajog.2007.08.028.

PMID:
18226629
[PubMed - indexed for MEDLINE]
3.

Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.

Bansal N, Herzog TJ, Seshan VE, Schiff PB, Burke WM, Cohen CJ, Wright JD.

Obstet Gynecol. 2008 Jul;112(1):64-70. doi: 10.1097/AOG.0b013e318176157c.

PMID:
18591309
[PubMed - indexed for MEDLINE]
4.

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.

Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS.

Gynecol Oncol. 2008 Jun;109(3):370-6. doi: 10.1016/j.ygyno.2008.02.006. Epub 2008 Apr 18.

PMID:
18395777
[PubMed - indexed for MEDLINE]
5.

Patterns and progress in ovarian cancer over 14 years.

Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, Berek JS, Osann K.

Obstet Gynecol. 2006 Sep;108(3 Pt 1):521-8.

PMID:
16946210
[PubMed - indexed for MEDLINE]
6.

Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States.

Chan JK, Zhang M, Hu JM, Shin JY, Osann K, Kapp DS.

J Surg Oncol. 2008 Feb 1;97(2):103-7.

PMID:
17979133
[PubMed - indexed for MEDLINE]
7.
8.

Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women.

Matthews RP, Hutchinson-Colas J, Maiman M, Fruchter RG, Gates EJ, Gibbon D, Remy JC, Sedlis A.

Gynecol Oncol. 1997 May;65(2):206-12.

PMID:
9159326
[PubMed - indexed for MEDLINE]
9.

Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy.

Kapp DS, Shin JY, Chan JK.

Cancer. 2008 Feb 15;112(4):820-30. doi: 10.1002/cncr.23245.

PMID:
18189292
[PubMed - indexed for MEDLINE]
Free Article
10.

Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes?

Chan JK, Manuel MR, Cheung MK, Osann K, Husain A, Teng NN, Rao A, Carlson RW, Whittemore AS.

Gynecol Oncol. 2006 Sep;102(3):508-12. Epub 2006 Feb 17.

PMID:
16483640
[PubMed - indexed for MEDLINE]
11.

Age-specific survival of women with endometrioid adenocarcinoma of the uterus.

Farley JH, Nycum LR, Birrer MJ, Park RC, Taylor RR.

Gynecol Oncol. 2000 Oct;79(1):86-9.

PMID:
11006037
[PubMed - indexed for MEDLINE]
12.

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers.

Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, Powell MA, Hendrickson MR, Kapp DS, Chan JK.

Br J Cancer. 2006 Mar 13;94(5):642-6.

PMID:
16495918
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.

Pothuri B, Ramondetta L, Eifel P, Deavers MT, Wilton A, Alektiar K, Barakat R, Soslow RA.

Gynecol Oncol. 2006 Dec;103(3):948-51. Epub 2006 Jul 25.

PMID:
16870239
[PubMed - indexed for MEDLINE]
14.

Prognostic factors for uterine cancer in reproductive-aged women.

Lee NK, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Kapp DS, Osann K, Chan JK.

Obstet Gynecol. 2007 Mar;109(3):655-62.

PMID:
17329517
[PubMed - indexed for MEDLINE]
15.

The outcomes of 27,063 women with unstaged endometrioid uterine cancer.

Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS.

Gynecol Oncol. 2007 Aug;106(2):282-8.

PMID:
17662377
[PubMed - indexed for MEDLINE]
16.

Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.

Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC; Gynecologic Oncology Group.

Cancer. 2008 May 15;112(10):2202-10. doi: 10.1002/cncr.23390.

PMID:
18348296
[PubMed - indexed for MEDLINE]
Free Article
17.

Adjuvant radiation therapy in stage III node-positive uterine cancer.

Schmid S, Hsu IC, Hu JM, Sherman AE, Osann K, Kapp DS, Chan JK.

Gynecol Oncol. 2009 Nov;115(2):239-43. doi: 10.1016/j.ygyno.2009.07.005. Epub 2009 Aug 12.

PMID:
19679341
[PubMed - indexed for MEDLINE]
18.

Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.

Hoogendoorn WE, Hollema H, van Boven HH, Bergman E, de Leeuw-Mantel G, Platteel I, Fles R, Nederlof PM, Mourits MJ, van Leeuwen FE; Comprehensive Cancer Centers TAMARISK-group.

Breast Cancer Res Treat. 2008 Nov;112(1):99-108. Epub 2007 Dec 7.

PMID:
18064567
[PubMed - indexed for MEDLINE]
19.

Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.

Page BR, Pappas L, Cooke EW, Gaffney DK.

Int J Gynecol Cancer. 2012 May;22(4):593-8. doi: 10.1097/IGC.0b013e3182412ebd.

PMID:
22343970
[PubMed - indexed for MEDLINE]
20.

Cancer of the uterine corpus among Hispanic women living in the United States: patterns of staging, diagnosis, and primary treatment.

Díaz-Montes TP, Alberg A, Zahurak ML, Trimble EL, Bristow RE.

Gynecol Oncol. 2005 Mar;96(3):753-9.

PMID:
15721422
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk